Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial.
BMJ. 2020 May 14;369:m1849. doi: 10.1136/bmj.m1849.
BMJ. 2020.
PMID: 32409561
Free PMC article.
Clinical Trial.